Y-Intercept (HK)’s Tandem Diabetes Care TNDM Stock Holding History

Y-Intercept (HK)’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.41M	Sell	147,914 -166,739	-53%	-$3.13M	0.05%	533
2026 Q2	$4.75M	Buy	314,653 +236,774	+304%	+$4.13M	0.09%	296
2026 Q1	$1.49M	Sell	77,879 -6,107	-7%	-$133K	0.03%	857
2025 Q4	$1.85M	Buy	83,986 +27,061	+48%	+$488K	0.04%	662
2025 Q3	$691K	Buy	+56,925	New	+$771K	0.02%	1141
2025 Q1	–	Sell	-14,147	Closed	-$510K	–	1609
2024 Q4	$510K	Buy	+14,147	New	+$479K	0.03%	715
2024 Q2	–	Sell	-25,028	Closed	-$886K	–	1924
2024 Q1	$886K	Buy	25,028 +3,661	+17%	+$98.1K	0.07%	438
2023 Q4	$632K	Buy	+21,367	New	+$443K	0.06%	485
2023 Q3	–	Sell	-14,265	Closed	-$350K	–	1597
2023 Q2	$350K	Buy	+14,265	New	+$459K	0.04%	707
2022 Q3	–	Sell	-8,116	Closed	-$480K	–	1270
2022 Q2	$480K	Buy	+8,116	New	+$666K	0.06%	442

Other funds holding TNDM

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Y-Intercept (HK)'s TNDM Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Tandem Diabetes Care (TNDM) stake by 53% in Q3 2026, selling an estimated $3.13M and leaving 147,914 shares worth $2.41M. The position accounts for 0.05% of the portfolio, ranked #533.

Y-Intercept (HK) first reported a position in TNDM in Q2 2022 and has held it in 10 quarters since. The position peaked at $4.75M in Q2 2026. 32 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

Y-Intercept (HK) held 147,914 shares of Tandem Diabetes Care worth $2.41M as of Q3 2026.
Y-Intercept (HK) sold 166,739 Tandem Diabetes Care shares in Q3 2026, an estimated $3.13M.
Tandem Diabetes Care made up 0.05% of Y-Intercept (HK)'s portfolio in Q3 2026, its #533 holding.
Y-Intercept (HK) first reported a position in Tandem Diabetes Care in Q2 2022 and has held it in 10 quarters since.
Y-Intercept (HK)'s Tandem Diabetes Care position peaked at $4.75M in Q2 2026.
32 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.